The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
The Journal of Immunology, 2003, 170: 665-666.
Copyright © 2003 by The American Association of Immunologists

IN THIS ISSUE

You’re only as old as ... ?


The immune response is known to change as a person ages and is influenced by chemokines and their receptors, which contribute to the recruitment of lymphocytes and APCs to a particular site. Mo et al. (p. 895 ) used DNA microarrays, ribonuclease protection assays, protein analysis and functional assays to examine the expression of chemokine receptors in CD4+ T cell subsets in aged (20–22 mo old) compared to young (3–4 mo old) mice. They document changes in chemokine receptor pattern with age that were not strain specific but that were partially reversed by caloric restriction. Expression of chemokine receptors characteristic of both naive and memory T cells increased with age, suggesting that the observed changes in expression were not due solely to the known shift from naive to memory phenotype during aging. Similarly, expression of chemokine receptors associated with both Th1 and Th2 cells increased with age, suggesting that the age-associated shift in the Th1/Th2 profile cannot fully explain the observed results. These findings may explain some of the underlying mechanisms for the different clinical course observed in elderly compared to younger individuals in diseases such as AIDS and rheumatoid arthritis.

Signaling for dendritic cell maturation


Upon encountering a pathogen in peripheral tissues, immature dendritic cells take up the Ag, undergo maturation, and migrate to lymph nodes to present the Ag to T cells. Dendritic cells express a variety of receptors involved in the Ag uptake that initiates maturation. Sedlik et al. (p. 846 ) used complementation of Rag-/- {gamma}c-/- mice with Syk-/- fetal liver cells to generate Syk-/- bone marrow-derived dendritic cells. They show that the genetic deletion of the tyrosine kinase Syk did not block differentiation of immature dendritic cells from the bone marrow, or responses to LPS, TNF-{alpha}, or CpG. However, Ag presentation and cell maturation induced via Fc{gamma}R (receptors for immune complexes) were abrogated by deletion of Syk. These findings indicate that proximal events in dendritic cell signal transduction are different for different maturation stimuli. Since the maturation state of dendritic cells appears to influence whether the engagement of the T cell results in tolerance or an immune response, these findings may shed light on the development of autoimmunity.

Experience counts


It is well established that a second encounter with a pathogen results in a more rapid immune response than the initial encounter. However, the mechanisms underlying the elevated secondary response of memory B cells, compared to that of naive B cells during the primary response, have not been fully elucidated. Tangye et al. (p. 686 ) demonstrated that human memory B cells have an increased intrinsic capacity to proliferate and up-regulate CD38 in response to CD40 ligand, IL-2, and IL-10, compared to naive B cells. Memory B cells entered cell division earlier than naive B cells and a greater number of memory cells were recruited into cell cycle, although the actual rate of proliferation of both groups was similar. Both IgM-expressing and Ig isotype-switched memory cells behaved similarly. Memory B cells that differentiated into CD38+ cells following CD40 ligand stimulation proliferated more rapidly than CD38- cells. The authors suggest that these rapidly proliferating CD38+ cells may correspond to plasmablasts observed in vivo.

Interfer(on)ing with proliferation

Type I IFNs, produced by a variety of cells upon viral infection, are known to inhibit cell proliferation. This presents a biological conundrum, since the host must mount an immune response that involves T cell proliferation in order to eradicate the viral infection. The paper by Dondi et al. (p. 749 ) addresses the regulation of T cell function by type I IFNs. While the entry of naive resting cells into cycle following stimulation was delayed by IFN-{alpha}, no effect was observed on activated T cells. Activated T cells, regardless of subset type, mounted a poor transcriptional response to IFN-{alpha} or IFN-{beta}.The decline in the transcriptional response to IFN occurred early after T cell activation, before cells began to proliferate. However, the residual transcriptional response to IFN-{alpha} in activated T cells was sufficient to inhibit viral replication in these cells. Therefore, the changes that occur in the cell upon engagement of the TCR appear to alter the cell’s responsiveness to type I IFNs.

CD40 ligand mRNA stability

CD40 ligand, a TNF-family member expressed by Ag-activated CD4+ T cells, plays a key role in the regulation of humoral and cellular immune responses by engaging CD40 on B cells and professional APC. The outcome of the response to CD40 ligand binding is influenced by the duration of CD40 ligand expression. For example, sustained expression favors differentiation of germinal center B cells to memory B cells whereas transient expression promotes differentiation of germinal center B cells to plasmacytoid B cells. The regulation of CD40 ligand expression occurs at both transcriptional and posttranscriptional levels. Kosinski et al. (p. 979 ) examined factors influencing the stability of CD40 ligand mRNA. They previously demonstrated the binding of a protein complex, called Complex I, within the pyrimidine rich sequence in the 3' untranslated region of CD40 ligand mRNA. They now show that binding of Complex I increased the stability of the CD40 ligand transcript. Polypyrimidine tract-binding protein was identified as a component, but not the sole constituent, of Complex I. Two additional motifs in the 3' untranslated region of CD40 ligand mRNA were shown to bind RNA-binding protein complexes structurally related, but not identical to, Complex I.

Complement signaling in fibroblasts

Fibroblasts are key cells in the wound repair process. During the inflammatory response to wounding, activated complement components elicit intracellular signals upon binding to fibroblasts. C1q is the initiator of the classical complement cascade and consists of collagen-like tails and globular heads. The C1q tail induces mitotic arrest in human fibroblasts. Bordin and Whitfield (p. 667 ) investigated the effect of C1q treatment on the stress-activated mitogen-activated protein kinase (MAPK) signaling pathway in fibroblasts. Increased phosphorylation of components of the p38 MAPK pathway occurred in response to C1q tails or the intact C1q molecule, but not to C1q globular heads. Signaling through p38 MAPK was dependent, in part, upon binding of C1q tails to the C1q receptor calreticulin and correlated with the appearance of apoptotic nuclei in the cells. Calreticulin is one of several possible receptors identified for C1q and the findings reported here strengthen its candidacy as a functional receptor. The authors conclude that p38 MAPK signaling is involved in the mitotic arrest and apoptosis observed in fibroblasts treated with C1q tails.

In vivo imaging


Airway epithelial cells play a role in acute inflammatory lung diseases such as asthma, cystic fibrosis, pneumonia, and acute respiratory distress syndrome. The transcription factor NF-{kappa}B is also involved in lung inflammation. Sadikot et al. (p. 1091 ) used a novel technique to study the involvement of epithelial cell NF-{kappa}B in lung inflammation. Using adenoviral vectors, they transfected genes involved in NF-{kappa}B activation into lung epithelial cells of transgenic mice expressing the luciferase gene under control of an NF-{kappa}B-dependent promoter. This technique allowed in vivo and in vitro measurement of NF-{kappa}B translocation via activation of the luciferase gene. The authors showed that NF-{kappa}B translocation and the subsequent activation of pulmonary epithelial cells was responsible for neutrophilic inflammation in the lungs. The type of in vivo imaging described in this study provides a tool to better understand the complexity of whole animal models for the study of human disease.

Aspirin is not for asthma


Lipid mediators contribute to the inflammatory response, and act rapidly to cause smooth muscle contraction. Cyclooxygenase (COX) is an enzyme involved in the synthesis of lipid mediators, specifically PGs, and exists in two isoforms: COX-1 is often constitutively expressed whereas COX-2 expression is associated with inflammation. The regulation of COX expression is cell-type specific. Pang et al. (p. 1043 ) investigated the regulation of COX-2 expression by nonsteroidal anti-inflammatory drugs in human airway smooth muscle cells and the part played by peroxisome proliferator-activated receptors (PPARs) in this process. They showed that COX-2 expression is induced by nonsteroidal anti-inflammatory drugs, as well as by PGE2, the main PG produced by human airway smooth muscle cells, and by the PPAR{gamma} activator 15d-PGJ2. They also showed that PPAR{gamma} is expressed in human airway smooth muscle cells, and that a PPAR response element in the COX-2 promoter is required for the induction of COX-2 expression by nonsteroidal anti-inflammatory drugs. Hence, despite their inhibition of COX enzyme activity, nonsteroidal anti-inflammatory drugs could paradoxically contribute to the inflammatory state by inducing COX-2 expression, perhaps helping to explain why nonsteroidal anti-inflammatory drugs are not effective in the treatment of airway inflammation.


Related articles in The JI:

Cyclooxygenase-2 Expression by Nonsteroidal Anti-inflammatory Drugs in Human Airway Smooth Muscle Cells: Role of Peroxisome Proliferator-Activated Receptors
Linhua Pang, Mei Nie, Lisa Corbett, and Alan J. Knox
The JI 2003 170: 1043-1051. [Abstract] [Full Text]  

Selective I{kappa}B Kinase Expression in Airway Epithelium Generates Neutrophilic Lung Inflammation
Ruxana T. Sadikot, Wei Han, M. Brett Everhart, Ornella Zoia, R. Stokes Peebles, E. Duco Jansen, Fiona E. Yull, John W. Christman, and Timothy S. Blackwell
The JI 2003 170: 1091-1098. [Abstract] [Full Text]  

Cutting Edge: Proliferating Fibroblasts Respond to Collagenous C1q with Phosphorylation of p38 Mitogen-Activated Protein Kinase and Apoptotic Features
Sandra Bordin and Douglas Whitfield
The JI 2003 170: 667-671. [Abstract] [Full Text]  

Intrinsic Differences in the Proliferation of Naive and Memory Human B Cells as a Mechanism for Enhanced Secondary Immune Responses
Stuart G. Tangye, Danielle T. Avery, Elissa K. Deenick, and Philip D. Hodgkin
The JI 2003 170: 686-694. [Abstract] [Full Text]  

Down-Modulation of Responses to Type I IFN Upon T Cell Activation
Elisabetta Dondi, Lars Rogge, Georges Lutfalla, Gilles Uzé, and Sandra Pellegrini
The JI 2003 170: 749-756. [Abstract] [Full Text]  

A Critical Role for Syk Protein Tyrosine Kinase in Fc Receptor-Mediated Antigen Presentation and Induction of Dendritic Cell Maturation
Christine Sedlik, Daniel Orbach, Philippe Veron, Edina Schweighoffer, Francesco Colucci, Romina Gamberale, Andrea Ioan-Facsinay, Sjef Verbeek, Paola Ricciardi-Castagnoli, Christian Bonnerot, Victor L. J. Tybulewicz, James Di Santo, and Sebastian Amigorena
The JI 2003 170: 846-852. [Abstract] [Full Text]  

T Cell Chemokine Receptor Expression in Aging
Ruran Mo, Jun Chen, Yin Han, Cecelia Bueno-Cannizares, David E. Misek, Pascal A. Lescure, Samir Hanash, and Raymond L. Yung
The JI 2003 170: 895-904. [Abstract] [Full Text]  

A Complex Containing Polypyrimidine Tract-Binding Protein Is Involved in Regulating the Stability of CD40 Ligand (CD154) mRNA
Penelope A. Kosinski, Jennifer Laughlin, Karnail Singh, and Lori R. Covey
The JI 2003 170: 979-988. [Abstract] [Full Text]  




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS